| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/22/2002 | WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 08/22/2002 | WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | WO2002004412A3 Tyrosine derivatives as phosphatase inhibitors |
| 08/22/2002 | US20020115864 Potentiators of glutamate receptor function |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | US20020115715 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders |
| 08/22/2002 | US20020115701 Have antipyretic action, analgesic action, antiinflammatory action, and particularly, selective inhibitory action on cyclooxygenase-2; ketomethylene intermediates |
| 08/22/2002 | US20020115685 Novel N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/22/2002 | US20020114770 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232143A1 Method for preparing dimetal sulfonyl amide salts |
| 08/21/2002 | EP1231919A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 08/21/2002 | EP1053224B1 Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament |
| 08/21/2002 | CN1365354A Novel naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 08/21/2002 | CN1365277A Method for treating chronic pain using MEK inhibitors |
| 08/20/2002 | US6437133 Method of catalytically removing a protective group containing an allyl group using a reducing agent |
| 08/20/2002 | US6436999 Diacyl-substituted guanidines, a process for their preparation, their use as medicine or diagnostic aid, and medicine containing them |
| 08/20/2002 | US6436989 Prodrugs of aspartyl protease inhibitors |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436914 2-hydroxy-3—(4-hydroxy-3-sulfonamidophenyl)—propylamines useful as beta 3 adrenergic agonists |
| 08/20/2002 | US6436152 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 08/15/2002 | WO2002062769A2 Preparation and purification of antiviral disulfonic acid disodium salt |
| 08/15/2002 | WO2002062763A2 Inhibition of raf kinase using quinolyl isoquinolyl or pyridyl ureas |
| 08/15/2002 | WO2002062749A1 Perfluorovinyl ether monomer having sulfonamide group |
| 08/15/2002 | WO2001072685B1 Polyamine analogues as cytotoxic agents |
| 08/15/2002 | US20020111369 Follicle stimulating hormone; contraceptives |
| 08/15/2002 | US20020111364 ABCA-1 elevating compounds |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111334 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith |
| 08/14/2002 | EP1230210A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders |
| 08/14/2002 | CN1364162A Alpha-phenyl-beta-ketosulfone |
| 08/14/2002 | CN1364156A Novel naphthalene ureas as glucose uptake enhancers |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/13/2002 | US6433187 Certain polycyclic compounds useful as tubulin-binding agents |
| 08/13/2002 | US6433185 N-(arylsulphonyl) amino acid derivatives, process for their preparation and pharmaceutical compositions containing them |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| 08/13/2002 | US6433172 Cardiovascular disorders; hypotensive agents; anticholesterol agents |
| 08/13/2002 | US6433017 Amphiphilic polyamine compounds |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6432933 Malaria therapy; alzheimer's disorders |
| 08/08/2002 | WO2002060874A1 Potassium channel inhibitors |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060421A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | WO2002006189A3 Aniline derivatives |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | US20020107390 Thyromimetic organic compounds |
| 08/08/2002 | US20020107271 Heterocyclic aromatic oxazole compounds and use thereof |
| 08/08/2002 | US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders. |
| 08/08/2002 | US20020107266 Amides used particularly in the treatment, prevention or amelioration of one or more symptoms of malaria or Chagas' disease; inhibiting the activity of falcipain or cruzain |
| 08/08/2002 | US20020107234 Lipoic acid derivatives and their use in treatment of disease |
| 08/08/2002 | DE10104369A1 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz Using 2-amino- (4-hydroxy-2-methanesulfonamidophenyl) ethanol for treating urinary incontinence |
| 08/08/2002 | CA2434565A1 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | CA2432783A1 Potassium channel inhibitors |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1136472A4 Aryl- and heteroarylamides of carboalkoxysulfanilic acids |
| 08/07/2002 | CN1362951A Dihetero-substituted metalloprotease inhibitors |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362945A Fluorine compounds and water and oil-repellant compositions |
| 08/06/2002 | US6429317 Indane derivatives for antipsychotic compositions |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429214 Inhibitors of bone resorption |
| 08/06/2002 | US6428780 Modified amino acid |
| 08/01/2002 | WO2002059080A2 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | WO2002059077A1 Aminoethanol derivatives |
| 08/01/2002 | WO2002059072A2 12-hydroxy-eicosatrienoic acid analogs and methods of use thereof |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | US20020103217 Triphenylpropanamide compounds; useful in treating inflammations but which do not demonstrate side effects associated with other anti-inflammatory treatments such as glucocorticoids |
| 08/01/2002 | US20020103192 Perfluoroalkylketones, ketooxazoles, ketoamides, ketoesters, and diketones, and their dihydroxy derivatives, such as 7-((1,1'-biphenyl)-3-yloxy)-1-(1,3-oxazol-2-yl)-1-heptanone |
| 08/01/2002 | US20020103171 7-and 9- carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds |
| 08/01/2002 | US20020102380 Ionic compounds in which the anionic load has been delocalized; ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions including polymerization |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 07/31/2002 | EP1226819A1 Inhibitor for 20-hete-yielding enzyme |
| 07/31/2002 | EP1226116A1 Processes for the preparation of sumatriptan and related compounds |
| 07/31/2002 | EP1225886A2 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits |
| 07/31/2002 | CN1361765A Inhibitors of aspartyl protease |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/30/2002 | US6426397 Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002057233A1 Mch antagonists and their use in the treatment of obesity |
| 07/25/2002 | WO2002057230A1 Il-8 receptor antagonists |
| 07/25/2002 | WO2002057220A1 Hydrazide derivatives and pharmaceutical compositions containing same |
| 07/25/2002 | WO2002057216A1 Terphenyl compounds bearing substituted amino groups |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002008177A3 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 07/25/2002 | US20020099241 For use in protecting plants against infestation by phytopathogenic microorganisms |
| 07/25/2002 | US20020099089 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-N-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2434636A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/24/2002 | EP1224171A1 Beta disubstituted metalloprotease inhibitors |
| 07/24/2002 | CN1360577A Hydroxamic acid derivs. as matrix metalloprotease inhibitors |
| 07/24/2002 | CN1360574A Process for preparation of tricyclic amino alcohol derivs. |
| 07/24/2002 | CN1360571A Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 07/24/2002 | CN1088057C Process for production of sulfonamides |